N/A
Manufactured by AmerisourceBergen Drug Corporation
19 FDA adverse event reports analyzed
Last updated: 2026-04-15
LIQUID BANDAGE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by AmerisourceBergen Drug Corporation. The most commonly reported adverse reactions for LIQUID BANDAGE include MUSCLE SPASMS, APPLICATION SITE FISSURE, BURNING SENSATION, CATHETER MANAGEMENT, DIABETES MELLITUS. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for LIQUID BANDAGE.
Out of 3 classified reports for LIQUID BANDAGE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 19 FDA FAERS reports that mention LIQUID BANDAGE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include MUSCLE SPASMS, APPLICATION SITE FISSURE, BURNING SENSATION, CATHETER MANAGEMENT, DIABETES MELLITUS, MULTIPLE SCLEROSIS. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list AmerisourceBergen Drug Corporation in connection with LIQUID BANDAGE. Always verify the specific product and NDC with your pharmacist.